MEDEA

What MEDEA does

MEDEA (Medea Inc.) is a privately-held healthcare and pharmaceutical distribution company headquartered in Pleasanton, California, that evolved from a consumer technology business into a government-focused medical supply distributor. Founded in 2014 as the maker of a Bluetooth-enabled programmable LED vodka bottle, the company pivoted in March 2020 to PPE production and distribution during the COVID-19 pandemic, creating the Medea Medical Products division. Since the pivot, MEDEA has built a healthcare distribution platform serving federal, state, and local government agencies (FEMA, US Army/DoD, State of California, Orange County, Montana), healthcare providers, harm reduction organizations, and major retailers, with distribution reach across 40+ US states, Canada, and Europe. The company employs 11-50 people and operates from three California locations (Pleasanton HQ, Livermore warehouse, Newport Beach office) under the leadership of founder Brandon Laidlaw (CEO and Chairman).

The company's product portfolio spans four core categories: OTC Pharmaceuticals (including generic naloxone 4mg), Rx Pharmaceuticals (200+ products including APIs and finished dosage forms serving federal, state, and provincial government programs, public hospitals, and correctional facilities), Medical Supplies (PPE, naloxone cabinets, emergency reversal kits, drug deactivation/disposal solutions, medical disposables), and Diagnostic Tests (multi-panel RSV, Influenza A/B, COVID-19 tests in OTC and POC formats). Key product lines include Kloxxado (8mg naloxone) distributed under an authorized Hikma USA partnership, affordable insulin, and COVID-19 rapid antigen tests supplied under a $190.1M US Army contract. The company also retains a legacy technology segment, TechCentrix, which licenses patented Bluetooth-enabled LED display technology internationally to third-party manufacturers. Notable milestones include delivery of 25M+ masks and N95 respirators to FEMA, 2M+ naloxone doses distributed to harm reduction organizations, and a partnership with CalOptima Health for 100,000 naloxone units in Southern California.

MEDEA's business model is built on multiple revenue streams: government procurement contracts won through competitive bidding, authorized pharmaceutical distribution partnerships (Hikma, Acon Laboratories, Quidel), retail channel sales through big-box partners (Costco, Walmart, Lowe's, Sam's Club, Safeway, Von's, Albertsons), and licensing royalties from TechCentrix. The company owns four wholly-owned subsidiaries (Medea Medical Products, Medea PPE, TechCentrix, Medea Charitable Foundation), has registered patents for LED display technology, label designs, and consumer data utility, and operates distribution services powered by a proprietary ERP and order management platform. The company has not raised public equity, is privately held under Laidlaw family leadership, and appears to be primarily funded by working capital generated from large government contracts.

Name

MEDEA

Legal name

Medea Inc.

Website

https://medeausa.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

MEDEA is a privately-held pharmaceutical and medical supply distributor serving federal and state government agencies, healthcare providers, and major retailers with FDA-approved pharmaceuticals, PPE, diagnostic tests, and naloxone products across 40+ US states, Canada, and Europe.

Ownership category

akta.pro rank

Headquarters

HQ city

Pleasanton

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Government Contracts: Major federal and state government procurement contracts including FEMA (25M+ masks), Department of Defense ($190M diagnostic tests), and State of California (5-year PPE contract). Recurring competitive contract wins through procurement processes.
2. Pharmaceutical Distribution: Distribution of naloxone products (Kloxxado) through authorized distributors and directly to healthcare providers and harm reduction organizations. Includes 2+ million naloxone doses distributed.
3. Retail Product Sales: Sale of consumer health and safety products through big box retail partners including Costco, Walmart, Lowe's, Sam's Club, Safeway, Von's, and Albertsons.
4. LED Technology Licensing: Licensing of patented LED technology through TechCentrix subsidiary to third-party manufacturers and brands.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Core offering

MEDEA is a healthcare product distribution company that supplies FDA-approved pharmaceuticals (including naloxone/Kloxxado as an authorized Hikma USA distributor), PPE, medical supplies, and diagnostic tests to government agencies, healthcare providers, and big box retailers across the United States. The company also operates a patented Bluetooth-enabled LED display technology licensing business through its TechCentrix subsidiary.

Product overview

Medea Inc. is a diversified healthcare distribution company that evolved from a consumer packaged goods company (featuring programmable LED technology on vodka bottles) into a pharmaceutical and medical supplies distributor. The current portfolio centers on four core product categories: (1) OTC Pharmaceuticals including generic naloxone 4mg for harm reduction programs; (2) Rx Pharmaceuticals offering over 200 prescription medications including APIs and finished dosage forms for government healthcare systems; (3) Medical Supplies encompassing PPE, naloxone cabinets, emergency reversal kits, and medical disposables; and (4) Diagnostic Tests for RSV, Influenza A/B, and COVID-19 in OTC and POC formats. The company operates through a Distribution Services division providing end-to-end fulfillment, warehousing, and proprietary ERP solutions. Key pharmaceutical products include Kloxxado (8mg naloxone) as an authorized Hikma USA distributor, affordable insulin, and COVID-19 rapid antigen tests supplied under a $190M Army contract. A legacy technology segment, TechCentrix, licenses patented Bluetooth-enabled LED display technology for interactive consumer and business applications. Medea primarily serves government agencies, healthcare providers, and retail channels across the United States.

Differentiator

Problem solved

Functional benefit

Brands

• Medea Medical Products: Division focused on PPE production and medical supply distribution during and after the COVID-19 pandemic.
• Medea PPE
• TechCentrix
• Medea Vodka
• Kloxxado

Products and services

• OTC Pharmaceuticals Over-the-counter pharmaceutical products including generic naloxone 4mg, supporting public health initiatives, emergency preparedness, and harm-reduction strategies across government programs.
• Rx Pharmaceuticals
• Medical Supplies
• Diagnostic Tests
• Distribution Services
• Kloxxado (8mg Naloxone)
• Affordable Insulin Affordable insulin products aimed at reducing the cost of essential medicine, distributed through state and federal programs.
• TechCentrix Technology Platform Licensed interactive LED technology platform enabling businesses to create dynamic marketing campaigns with personally programmable LED displays, featuring Bluetooth capability, mobile apps for iOS and Android, and back-end cloud server technology.

Quantifiable outcome

• 2+ million naloxone doses distributed to harm reduction organizations
• +2 more outcomes

Named customers12 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

17 partnerships are on record, tiered flagship, core and minor.

• US Army / Department of DefenseflagshipStrategic or Co-development Partner$190M contract award for diagnostic tests - the largest government contract secured by MEDEA, demonstrating ability to serve federal defense healthcare needs
• FEMAcoreStrategic or Co-development Partner25M+ face masks and N95 respirators delivered for national emergency response - major federal emergency preparedness partnership
• State of CaliforniacoreStrategic or Co-development Partner5-year PPE procurement contract - ongoing state-level government partnership for emergency supplies
• Hikma USAcoreChannel Partner/ Reseller/ DistributorAuthorized distributor of Kloxxado (naloxone) - pharmaceutical distribution partnership for opioid crisis response products
• Acon LaboratoriescoreChannel Partner/ Reseller/ DistributorAuthorized distributor - global leader in diagnostic and medical devices partnership for diagnostic product distribution
• Quidel DiagnosticsminorChannel Partner/ Reseller/ DistributorAuthorized distributor for diagnostic products - expanded diagnostic distribution channel
• CalOptima HealthminorChannel Partner/ Reseller/ DistributorPartnership to distribute naloxone to harm reduction organizations in Southern California for public health outreach
• Orange CountyminorStrategic or Co-development PartnerPartnership to distribute 8mg naloxone for local opioid crisis response efforts
• TechCentrixcoreOEM/ Whitelabel/ Licensing PartnerWholly-owned subsidiary created specifically for licensing patented LED technology to third-party manufacturers and brands
• Shaquille O'NealminorOthersTechnology Advisory Committee member providing guidance on technology and brand initiatives
• NHL Alumni AssociationminorGTM or Marketing PartnerSports network partnership for health safety product distribution to alumni networks and venues
• Anaheim DucksminorGTM or Marketing PartnerSports venue partnership for health safety products at NHL games and events
• CostcocoreChannel Partner/ Reseller/ DistributorMajor retail distribution partner for consumer health and safety products
• WalmartcoreChannel Partner/ Reseller/ DistributorMajor retail distribution partner for consumer health and safety products
• Lowe'scoreChannel Partner/ Reseller/ DistributorMajor retail distribution partner for consumer health and safety products
• End OverdoseminorChannel Partner/ Reseller/ DistributorHarm reduction organization recipient of naloxone distribution
• Harm Reduction CircleminorChannel Partner/ Reseller/ DistributorHarm reduction organization recipient of naloxone distribution

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Medline Industries: Large privately-held manufacturer and distributor of medical supplies and PPE with deep federal-government and health-system relationships. Closest private-sector analog to Medea's PPE and medical-supply distribution business.
• Cencora (formerly AmerisourceBergen): One of the 'Big Three' US pharmaceutical distributors. Operates the same wholesale-drug distribution model as Medea at multi-billion-dollar scale, including specialty and government channels.
• McKesson Corporation: The largest pharmaceutical distributor in North America. Comparable to Medea as a wholesale distributor of drugs and medical products to government, retail, and healthcare customers, though at vastly greater scale and breadth.
• Cardinal Health: Major US pharmaceutical and medical-product distributor serving pharmacies, hospitals, and government customers. Directly comparable wholesale-drugs and medical-supplies distribution model to Medea.

Direct peers

• Henry Schein: Distributor of medical, dental, and animal-health supplies to office-based practitioners, government, and institutional customers. Highly comparable distribution-platform model to Medea's healthcare and government segments.
• Owens & Minor: Medical/surgical supply distributor with significant federal government and acute-care business. Comparable to Medea's PPE and medical-supply distribution into government and hospital channels.
• Government Scientific Source (GSS): Specialty distributor of medical, scientific, and laboratory products to federal, state, and local government agencies. Closest direct peer in the government-focused medical-distribution niche Medea occupies.
• Concordance Healthcare Solutions: Independent medical-surgical supply distributor serving acute-care, government, and retail customers. Comparable mid-market distributor profile with overlapping government and healthcare-provider channels.

Others

• QuidelOrtho: Diagnostics manufacturer (combined Quidel + Ortho Clinical Diagnostics) whose products Medea distributes via an authorized channel. Adjacent rather than directly competitive, but central to Medea's diagnostic-test offering.
• Hikma Pharmaceuticals: Manufacturer of generic and specialty pharmaceuticals including Kloxxado naloxone. Not a direct competitor but a critical upstream supplier and authorized-distribution partner for Medea's opioid-response portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/medea-usa
• Instagraminstagram.com/medea.inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MEDEA